Upstream Bioprocessing Market Size & Share Report, 2032

Upstream Bioprocessing Market - By Product (Bioreactors/Fermenters, Cell Culture Products, Filters), Usage Mode (Multi-use, Single-use), Mode (In-house, Outsourced), Application (Monoclonal Antibody, Vaccine Production), End-user – Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing adoption of single-use bioprocessing systems

3.2.1.2&nbsp;&nbsp;&nbsp;Rising implementation of process analytical technology (PAT)

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing demand for biopharmaceuticals

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High capital costs

3.2.2.2&nbsp;&nbsp;&nbsp;Technical and operational challenges related to upstream bioprocessing

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.5.1&nbsp;&nbsp;&nbsp; Supplier power

3.5.2&nbsp;&nbsp;&nbsp; Buyer power

3.5.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.5.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.5.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.6&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Bioreactors/Fermenters

5.3&nbsp;&nbsp;&nbsp; Cell culture products

5.4&nbsp;&nbsp;&nbsp; Filters

5.5&nbsp;&nbsp;&nbsp; Bioreactor accessories

5.6&nbsp;&nbsp;&nbsp; Bags &amp; containers

5.7&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Usage Mode, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Multi-use

6.3&nbsp;&nbsp;&nbsp; Single-use

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Mode, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; In-house

7.3&nbsp;&nbsp;&nbsp; Outsourced

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Monoclonal antibody production

8.3&nbsp;&nbsp;&nbsp; Vaccine production

8.4&nbsp;&nbsp;&nbsp; Cell and gene therapy production

8.5&nbsp;&nbsp;&nbsp; Other applications

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-User, 2018 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Biopharmaceutical companies

9.3&nbsp;&nbsp;&nbsp; CDMOs and CROs

9.4&nbsp;&nbsp;&nbsp; Research and academic institutes

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Spain

10.3.5&nbsp;&nbsp;&nbsp;Italy

10.3.6&nbsp;&nbsp;&nbsp;Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;China

10.4.2&nbsp;&nbsp;&nbsp;Japan

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;South Africa

10.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Applikon Biotechnology

11.2&nbsp;&nbsp;&nbsp; Boehringer Ingelheim GmbH

11.3&nbsp;&nbsp;&nbsp; CellGenix GmbH

11.4&nbsp;&nbsp;&nbsp; Corning, Inc.

11.5&nbsp;&nbsp;&nbsp; Danaher Corporation (Cytvia)

11.6&nbsp;&nbsp;&nbsp; Eppendorf AG

11.7&nbsp;&nbsp;&nbsp; Merck KGaA

11.8&nbsp;&nbsp;&nbsp; PBS Biotech, Inc.

11.9&nbsp;&nbsp;&nbsp; Sartorius AG

11.10&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc. 
&nbsp;

Upstream Bioprocessing Market

Get a free sample of this report